TMCnet News

Microfluidic Market for Healthcare Application Market size to grow by USD 59.79 billion from 2022 to 2027, The use of paper-based microfluidic devices to be a key market trend - Technavio
[April 17, 2023]

Microfluidic Market for Healthcare Application Market size to grow by USD 59.79 billion from 2022 to 2027, The use of paper-based microfluidic devices to be a key market trend - Technavio


NEW YORK, April 17, 2023 /PRNewswire/ -- Technavio has been monitoring the microfluidic market for the healthcare application market, and it is expected to grow by USD 59.76 billion during the forecast period. As per the latest report, the market will progress at a CAGR of 20.16% from 2022 to 2027. This report aid business leaders with an up-to-date analysis that includes the study of the current market scenario, the latest trends and drivers that are likely to influence the market growth, and the overall market environment. An emerging trend in the market that is expected to fuel market growth is the use of paper-based microfluidic devices. Paper-based devices use hydrophobic channel walls, which These hydrophobic walls ensure controlled velocity and direction of liquid flow. The use of paper greatly reduces the cost of these devices and simplifies their disposal. The fabrication of microfluidic devices from paper technology is expected to have a significant impact on the microfluidic market during the forecast period. Click to get the Latest and Comprehensive Sample PDF Report within minutes!

Microfluidic Market for Healthcare Application Market 2023-2027: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our microfluidic market for healthcare application market report covers the following areas:

Key Driver

  • The compact size of microfluidic devices is one of the major drivers for the market growth during the forecast period. 
  • Because they are smaller and use fewer reagents, microfluidic devices save money and reduce medical waste.
  • These devices' high surface area-to-volume ratio and low thermal mass make it easier to control temperatures precisely, transfer heat quickly, and adjust quickly to changes in temperature.
  • The rapid diffusion of liquids boosts reaction precision and speed thanks to the small size of microfluidic devices.
  • Assay sensitivity is raised, measurement times are reduced, and microfluidic assay performance is enhanced as a result.

Microfluidic Market for Healthcare Application Market 2023-2027: Segmentation
Microfluidic Market for Healthcare Application Market is segmented as below:

  • Application 
    • In-vitro Diagnostics
    • Pharmaceutical Research
    • Drug Delivery Services
  • Material 
    • Polymer-based
    • Glass-based
    • Silicon-based
  • Geography 
    • North America
    • Europe
    • APAC
    • South America
    • Middle East And Africa

The market share growth by the in-vitro diagnostics segment will be significant for the market growth during the forecast period. Microfluidic diagnostic kits take full advantage of compact integrated systems for rapid turnaround. They provide immediate results and reduce costs. Cepheid's automated microfluidic polymerase chain reaction (PCR) is another system used for rapid screening and diagnosis of methicillin-resistant Staphylococcus aureus (MRSA) infections in hospitals, which helps doctors track their patients' health regularly and patients monitor their own health. Hence, advantages like these drive segment growth.

The impact of different segments on market growth is crucial, learn more here, Request a Sample Report!

This study identifies Changes in the properties of fluids at microscopic level as one of the prime reasons challenging the microfluidic market for healthcare application market growth during the next few years.

Major Challenge

  • A major challenge hampering market growth is the changes in the properties of fluids at the microscopic level.
  • Microfluidics will quite often change their actual properties at a minuscule level. When compared to its behavior on a macro scale, a fluid behaves very differently at the microscale.
  • Energy dissipation, surface tension, and fluid resistance are just a few of the smaller-scale characteristics that come to mind. The Reynolds number looks at the impact of the force of a fluid with the impact of its thickness.
  • The Reynolds number drops very low at the micron scale, and the flow becomes laminar rather than turbulent. Liquids only mix through diffusion in laminar flow. In microfluidic devices, it is more challenging to achieve reactions because diffusion is a relatively slow mechanism.
  • As a consequence of this, measurement errors may occur, which may result in incorrect readings on a variety of medical tests.

What's New? -

  • Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession
  • Global competitiveness and key competitor positions
  • Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial - Buy the report!

Microfluidic Market for Healthcare Application Market 2023-2027: Vendor Analysis

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. We provide a detailed analysis of around 25 vendors operating in the Microfluidic Market for Healthcare Application Market, including some of the vendors such as 908 Devices Inc., Agilent Technologies Inc., bioMerieux SA, Bio Rad Laboratories Inc., Blacktrace Holdings Ltd., Cellix Ltd., Danaher Corp., Elveflow, Fluigent SA, General Electric Co., Hamilton Bonaduz AG, Illumina Inc., Microfluidic Chipshop GmbH, MICRUX FLUIDIC S.L., Perkin Elmer Inc., SMC Corp., Teledyne Technologies Inc., Thermo Fisher Scientific Inc., uFluidix Inc., and QIAGEN NV. Backed with competitive intelligence and benchmarking, our research reports on the Microfluidic Market for Healthcare Application Market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.

Vendor Offerings

  • 908 Devices Inc. - The company offers microfluidics for healthcare applications such as microfluidic CE.
  • Agilent Technologies Inc. - The company offers microfluidics for healthcare applications such as Agilent 2100 Bioanalyzer.
  • bioMerieux SA - The company offers microfluidics for healthcare applications such as Nuclisens EasyQ.

    Microfluidic Market for Healthcare Application Market 2023-2027: Key Highlights
  • CAGR of the market during the forecast period 2023-2027
  • Detailed information on factors that will assist microfluidic market for healthcare application market growth during the next five years
  • Estimation of the microfluidic market for healthcare application market size and its contribution to the parent market
  • Predictions on upcoming trends and changes in consumer behavior
  • The growth of the microfluidic market for healthcare application market
  • Analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of microfluidic market for healthcare application market vendors
     

Easy to get instant lifetime access to 17,000+ market research reports for exponential business growth.
Technavio's SUBSCRIPTION platform

Related Reports:

The predicted growth of the healthcare information software market size from 2021 to 2026 is USD 11.76 billion at a progressing CAGR of 7.9%. The report extensively covers healthcare information software market segmentation by application (HIS and PIS), deployment (On premises and Cloud based), and geography (North America, Europe, APAC, South America, and Middle East and Africa). A major factor driving growth in the market is the increasing adoption of EHRs.

The healthcare middleware market size is expected to increase by USD 1.76 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 9.75%. Furthermore, this report extensively covers healthcare middleware market segmentation by type (communication middleware, integration middleware, platform middleware, and others), deployment (on-premise, cloud-based, and hybrid), end-user (healthcare providers, life science organizations, healthcare payers, and clinical laboratories), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The rising amount of healthcare data is notably driving the healthcare middleware market growth.





Microfluidic Market For Healthcare Application Market Scope

Report Coverage

Details

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 20.16%

Market growth 2023-2027

USD 59.76 billion

Market structure

Fragmented

YoY growth 2022- 2023 (%)

19.47

Regional analysis

North America, Europe, APAC, South America, and Middle East and Africa

Performing market contribution

North America at 45%

Key countries

US, China, Japan, Germany, and UK

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

908 Devices Inc., Agilent Technologies Inc., bioMerieux SA, Bio Rad Laboratories Inc., Blacktrace Holdings Ltd., Cellix Ltd., Danaher Corp., Elveflow, Fluigent SA, General Electric Co., Hamilton Bonaduz AG, Illumina Inc., Microfluidic Chipshop GmbH, MICRUX FLUIDIC S.L., Perkin Elmer Inc., SMC Corp., Teledyne Technologies Inc., Thermo Fisher Scientific Inc., uFluidix Inc., and QIAGEN NV

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.


Browse for Technavio's Consumer Discretionary?Reports

Table Of Contents :

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Material
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
  • 2 Market Landscape
  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics
  • 3 Market Sizing
  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis 
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027 
    • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
    • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • 4 Historic Market Size
  • 4.1 Global microfluidic market for healthcare application 2017 - 2021 
    • Exhibit 18: Historic Market Size – Data Table on Global microfluidic market for healthcare application 2017 - 2021 ($ billion)
  • 4.2 Application Segment Analysis 2017 - 2021 
    • Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ billion)
  • 4.3 Material Segment Analysis 2017 - 2021 
    • Exhibit 20: Historic Market Size – Material Segment 2017 - 2021 ($ billion)
  • 4.4 Geography Segment Analysis 2017 - 2021 
    • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)
  • 4.5 Country Segment Analysis 2017 - 2021 
    • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)
  • 5 Five Forces Analysis
  • 5.1 Five forces summary
    • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers 
    • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers 
    • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants 
    • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes 
    • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
    • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
  • 5.7 Market condition
    • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
  • 6 Market Segmentation by Application
  • 6.1 Market segments
    • Exhibit 30: Chart on Application - Market share 2022-2027 (%)
    • Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
  • 6.2 Comparison by Application 
    • Exhibit 32: Chart on Comparison by Application
    • Exhibit 33: Data Table on Comparison by Application
  • 6.3 In-vitro diagnostics - Market size and forecast 2022-2027 
    • Exhibit 34: Chart on In-vitro diagnostics - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 35: Data Table on In-vitro diagnostics - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 36: Chart on In-vitro diagnostics - Year-over-year growth 2022-2027 (%)
    • Exhibit 37: Data Table on In-vitro diagnostics - Year-over-year growth 2022-2027 (%)
  • 6.4 Pharmaceutical research - Market size and forecast 2022-2027 
    • Exhibit 38: Chart on Pharmaceutical research - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 39: Data Table on Pharmaceutical research - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 40: Chart on Pharmaceutical research - Year-over-year growth 2022-2027 (%)
    • Exhibit 41: Data Table on Pharmaceutical research - Year-over-year growth 2022-2027 (%)
  • 6.5 Drug delivery services - Market size and forecast 2022-2027 
    • Exhibit 42: Chart on Drug delivery services - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 43: Data Table on Drug delivery services - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 44: Chart on Drug delivery services - Year-over-year growth 2022-2027 (%)
    • Exhibit 45: Data Table on Drug delivery services - Year-over-year growth 2022-2027 (%)
  • 6.6 Market opportunity by Application 
    • Exhibit 46: Market opportunity by Application ($ billion)
    • Exhibit 47: Data Table on Market opportunity by Application ($ billion)
  • 7 Market Segmentation by Material
  • 7.1 Market segments
    • Exhibit 48: Chart on Material - Market share 2022-2027 (%)
    • Exhibit 49: Data Table on Material - Market share 2022-2027 (%)
  • 7.2 Comparison by Material 
    • Exhibit 50: Chart on Comparison by Material
    • Exhibit 51: Data Table on Comparison by Material
  • 7.3 Polymer-based - Market size and forecast 2022-2027 
    • Exhibit 52: Chart on Polymer-based - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 53: Data Table on Polymer-based - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 54: Chart on Polymer-based - Year-over-year growth 2022-2027 (%)
    • Exhibit 55: Data Table on Polymer-based - Year-over-year growth 2022-2027 (%)
  • 7.4 Glass-based - Market size and forecast 2022-2027 
    • Exhibit 56: Chart on Glass-based - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 57: Data Table on Glass-based - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 58: Chart on Glass-based - Year-over-year growth 2022-2027 (%)
    • Exhibit 59: Data Table on Glass-based - Year-over-year growth 2022-2027 (%)
  • 7.5 Silicon-based - Market size and forecast 2022-2027 
    • Exhibit 60: Chart on Silicon-based - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 61: Data Table on Silicon-based - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 62: Chart on Silicon-based - Year-over-year growth 2022-2027 (%)
    • Exhibit 63: Data Table on Silicon-based - Year-over-year growth 2022-2027 (%)
  • 7.6 Market opportunity by Material 
    • Exhibit 64: Market opportunity by Material ($ billion)
    • Exhibit 65: Data Table on Market opportunity by Material ($ billion)
  • 8 Customer Landscape
  • 8.1 Customer landscape overview 
    • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 9 Geographic Landscape
  • 9.1 Geographic segmentation 
    • Exhibit 67: Chart on Market share by geography 2022-2027 (%)
    • Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
  • 9.2 Geographic comparison 
    • Exhibit 69: Chart on Geographic comparison
    • Exhibit 70: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027 
    • Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
    • Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027 
    • Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
    • Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 APAC - Market size and forecast 2022-2027 
    • Exhibit 79: Chart on APAC - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 80: Data Table on APAC - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 81: Chart on APAC - Year-over-year growth 2022-2027 (%)
    • Exhibit 82: Data Table on APAC - Year-over-year growth 2022-2027 (%)
  • 9.6 South America - Market size and forecast 2022-2027 
    • Exhibit 83: Chart on South America - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 84: Data Table on South America - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 85: Chart on South America - Year-over-year growth 2022-2027 (%)
    • Exhibit 86: Data Table on South America - Year-over-year growth 2022-2027 (%)
  • 9.7 Middle East and Africa - Market size and forecast 2022-2027 
    • Exhibit 87: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 88: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 89: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
    • Exhibit 90: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
  • 9.8 US - Market size and forecast 2022-2027 
    • Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
    • Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.9 China - Market size and forecast 2022-2027 
    • Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
    • Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.10 Germany - Market size and forecast 2022-2027 
    • Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
    • Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.11 UK - Market size and forecast 2022-2027 
    • Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
    • Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.12 Japan - Market size and forecast 2022-2027 
    • Exhibit 107: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 108: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
    • Exhibit 109: Chart on Japan - Year-over-year growth 2022-2027 (%)
    • Exhibit 110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • 9.13 Market opportunity by geography 
    • Exhibit 111: Market opportunity by geography ($ billion)
    • Exhibit 112: Data Tables on Market opportunity by geography ($ billion)
  • 10 Drivers, Challenges, and Trends
  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges 
    • Exhibit 113: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends
  • 11 Vendor Landscape
  • 11.1 Overview
  • 11.2 Vendor landscape
    • Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
    • Exhibit 115: Overview on factors of disruption
  • 11.4 Industry risks
    • Exhibit 116: Impact of key risks on business
  • 12 Vendor Analysis
  • 12.1 Vendors covered
    • Exhibit 117: Vendors covered
  • 12.2 Market positioning of vendors 
    • Exhibit 118: Matrix on vendor position and classification
  • 12.3 908 Devices Inc.
    • Exhibit 119: 908 Devices Inc. - Overview
    • Exhibit 120: 908 Devices Inc. - Product / Service
    • Exhibit 121: 908 Devices Inc. - Key offerings
  • 12.4 Agilent Technologies Inc. 
    • Exhibit 122: Agilent Technologies Inc. - Overview
    • Exhibit 123: Agilent Technologies Inc. - Business segments
    • Exhibit 124: Agilent Technologies Inc. - Key offerings
    • Exhibit 125: Agilent Technologies Inc. - Segment focus
  • 12.5 bioMerieux SA
    • Exhibit 126: bioMerieux SA - Overview
    • Exhibit 127: bioMerieux SA - Product / Service
    • Exhibit 128: bioMerieux SA - Key offerings
  • 12.6 Bio Rad Laboratories Inc. 
    • Exhibit 129: Bio Rad Laboratories Inc. - Overview
    • Exhibit 130: Bio Rad Laboratories Inc. - Business segments
    • Exhibit 131: Bio Rad Laboratories Inc. - Key news
    • Exhibit 132: Bio Rad Laboratories Inc. - Key offerings
    • Exhibit 133: Bio Rad Laboratories Inc. - Segment focus
  • 12.7 Blacktrace Holdings Ltd. 
    • Exhibit 134: Blacktrace Holdings Ltd. - Overview
    • Exhibit 135: Blacktrace Holdings Ltd. - Product / Service
    • Exhibit 136: Blacktrace Holdings Ltd. - Key offerings
  • 12.8 Cellix Ltd.
    • Exhibit 137: Cellix Ltd. - Overview
    • Exhibit 138: Cellix Ltd. - Product / Service
    • Exhibit 139: Cellix Ltd. - Key offerings
  • 12.9 Danaher Corp.
    • Exhibit 140: Danaher Corp. - Overview
    • Exhibit 141: Danaher Corp. - Business segments
    • Exhibit 142: Danaher Corp. - Key news
    • Exhibit 143: Danaher Corp. - Key offerings
    • Exhibit 144: Danaher Corp. - Segment focus
  • 12.10 Fluigent SA
    • Exhibit 145: Fluigent SA - Overview
    • Exhibit 146: Fluigent SA - Product / Service
    • Exhibit 147: Fluigent SA - Key offerings
  • 12.11 Illumina Inc.
    • Exhibit 148: Illumina Inc. - Overview
    • Exhibit 149: Illumina Inc. - Business segments
    • Exhibit 150: Illumina Inc. - Key news
    • Exhibit 151: Illumina Inc. - Key offerings
    • Exhibit 152: Illumina Inc. - Segment focus
  • 12.12 MICRUX FLUIDIC S.L.
    • Exhibit 153: MICRUX FLUIDIC S.L. - Overview
    • Exhibit 154: MICRUX FLUIDIC S.L. - Product / Service
    • Exhibit 155: MICRUX FLUIDIC S.L. - Key offerings
  • 12.13 Perkin Elmer Inc.
    • Exhibit 156: Perkin Elmer Inc. - Overview
    • Exhibit 157: Perkin Elmer Inc. - Business segments
    • Exhibit 158: Perkin Elmer Inc. - Key news
    • Exhibit 159: Perkin Elmer Inc. - Key offerings
    • Exhibit 160: Perkin Elmer Inc. - Segment focus
  • 12.14 QIAGEN NV
    • Exhibit 161: QIAGEN NV - Overview
    • Exhibit 162: QIAGEN NV - Product / Service
    • Exhibit 163: QIAGEN NV - Key news
    • Exhibit 164: QIAGEN NV - Key offerings
  • 12.15 Teledyne Technologies Inc. 
    • Exhibit 165: Teledyne Technologies Inc. - Overview
    • Exhibit 166: Teledyne Technologies Inc. - Business segments
    • Exhibit 167: Teledyne Technologies Inc. - Key news
    • Exhibit 168: Teledyne Technologies Inc. - Key offerings
    • Exhibit 169: Teledyne Technologies Inc. - Segment focus
  • 12.16 Thermo Fisher Scientific Inc. 
    • Exhibit 170: Thermo Fisher Scientific Inc. - Overview
    • Exhibit 171: Thermo Fisher Scientific Inc. - Business segments
    • Exhibit 172: Thermo Fisher Scientific Inc. - Key news
    • Exhibit 173: Thermo Fisher Scientific Inc. - Key offerings
    • Exhibit 174: Thermo Fisher Scientific Inc. - Segment focus
  • 12.17 uFluidix Inc.
    • Exhibit 175: uFluidix Inc. - Overview
    • Exhibit 176: uFluidix Inc. - Product / Service
    • Exhibit 177: uFluidix Inc. - Key offerings
  • 13 Appendix
  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist 
    • Exhibit 178: Inclusions checklist
    • Exhibit 179: Exclusions checklist
  • 13.3 Currency conversion rates for US$ 
    • Exhibit 180: Currency conversion rates for US$
  • 13.4 Research methodology
    • Exhibit 181: Research methodology
    • Exhibit 182: Validation techniques employed for market sizing
    • Exhibit 183: Information sources
  • 13.5 List of abbreviations 
    • Exhibit 184: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/microfluidic-market-for-healthcare-application-market-size-to-grow-by-usd-59-79-billion-from-2022-to-2027--the-use-of-paper-based-microfluidic-devices-to-be-a-key-market-trend---technavio-301797708.html

SOURCE Technavio


[ Back To TMCnet.com's Homepage ]